| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance D Ge, J Fellay, AJ Thompson, JS Simon, KV Shianna, TJ Urban, ... Nature 461 (7262), 399-401, 2009 | 4554 | 2009 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2163 | 2017 |
| Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised … International Carotid Stenting Study investigators The Lancet 375 (9719), 985-997, 2010 | 1579 | 2010 |
| Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection GR Foster, N Afdhal, SK Roberts, N Bräu, EJ Gane, S Pianko, E Lawitz, ... New England Journal of Medicine 373 (27), 2608-2617, 2015 | 1064 | 2015 |
| Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus AJ Thompson, AJ Muir, MS Sulkowski, D Ge, J Fellay, KV Shianna, ... Gastroenterology 139 (1), 120-129. e18, 2010 | 971 | 2010 |
| Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Senkus, S Kyriakides, F Penault-Llorca, P Poortmans, A Thompson, ... Annals of oncology 24, vi7-vi23, 2013 | 713 | 2013 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 569 | 2014 |
| ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C J Fellay, AJ Thompson, D Ge, CE Gumbs, TJ Urban, KV Shianna, LD Little, ... Nature 464 (7287), 405-408, 2010 | 554 | 2010 |
| Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers AJV Thompson, T Nguyen, D Iser, A Ayres, K Jackson, M Littlejohn, ... Hepatology 51 (6), 1933-1944, 2010 | 546 | 2010 |
| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 516 | 2019 |
| Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia T Nguyen, AJV Thompson, S Bowden, C Croagh, S Bell, PV Desmond, ... Journal of hepatology 52 (4), 508-513, 2010 | 514 | 2010 |
| IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C TJ Urban, AJ Thompson, SS Bradrick, J Fellay, D Schuppan, KD Cronin, ... Hepatology 52 (6), 1888-1896, 2010 | 465 | 2010 |
| Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein K Visvanathan, NA Skinner, AJV Thompson, SM Riordan, V Sozzi, ... Hepatology 45 (1), 102-110, 2007 | 462 | 2007 |
| Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin JJ McCarthy, JH Li, A Thompson, S Suchindran, XQ Lao, K Patel, ... Gastroenterology 138 (7), 2307-2314, 2010 | 456 | 2010 |
| A global scientific strategy to cure hepatitis B PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ... The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019 | 453 | 2019 |
| Hepatitis B surface antigen quantification: why and how to use it in 2011–a core group report HLY Chan, A Thompson, M Martinot-Peignoux, T Piratvisuth, M Cornberg, ... Journal of hepatology 55 (5), 1121-1131, 2011 | 447 | 2011 |
| A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice HL Tillmann, AJ Thompson, K Patel, M Wiese, H Tenckhoff, HD Nischalke, ... Gastroenterology 139 (5), 1586-1592. e1, 2010 | 428 | 2010 |
| Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines S Dumbreck, A Flynn, M Nairn, M Wilson, S Treweek, SW Mercer, ... bmj 350, 2015 | 423 | 2015 |
| An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response A Mangia, AJ Thompson, R Santoro, V Piazzolla, HL Tillmann, K Patel, ... Gastroenterology 139 (3), 821-827. e1, 2010 | 423 | 2010 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 415 | 2014 |
